Mordor Intelligence has published a new report on plasma fractionation market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction:
The plasma fractionation market size is valued at USD 38.88 billion in 2025 and is forecast to reach USD 58.47 billion by 2030, posting an 8.51% CAGR over 2025-2030.
This expansion reflects broader trends in healthcare utilization, where chronic disease prevalence and the adoption of outpatient care models are influencing consumption of plasma-derived therapies. Healthcare providers are increasingly reliant on a steady supply of fractionated plasma products to support treatment protocols, underscoring the importance of efficient production and distribution systems. The plasma fractionation market analysis shows how these forces combine to support future growth prospects across regions and segments.
Key Trends in the Plasma Fractionation Market
Growing Demand for Plasma-Derived Therapeutics
One of the biggest drivers in the plasma fractionation market trends is the rise in demand for immunoglobulins and other plasma-derived proteins. These products have become standard in treating immune deficiencies, autoimmune diseases, and neurological disorders, contributing to consistent uptake of plasma fractionation outputs.
Shifts in End-User Channels
While hospitals and clinics continue to account for a large share of plasma fractionation demand due to complex infusion requirements, alternative care settings are gaining attention. Home care models and specialty infusion centers are gradually attracting a higher share of utilization, particularly as patients seek more convenient treatment options and payers look for cost-efficient delivery modes.
Regional Growth Dynamics
North America remains a leading region in the plasma fractionation market with extensive plasma collection infrastructure and supportive regulatory environments that facilitate rapid product adoption. At the same time, the Asia-Pacific region is emerging with robust expansion plans as governments invest in domestic fractionation plants to reduce import dependence and strengthen healthcare supply chains.
Market Segmentation:
The plasma fractionation market analysis identifies critical segments that shape overall market dynamics, each with distinct growth patterns and strategic relevance:
By Product
- Immunoglobulins
- Coagulation Factors
- Albumin
- Protease Inhibitors
- Other Plasma-Derived Products
By Application
- Neurology
- Immunology
- Hematology
- Pulmonology
- Critical Care & Trauma
- Other Applications
By End-User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Plasma Collection Centers & Blood Banks
- Other End-Users
By Sector
- Private Fractionators
- Public Fractionators
By Geography
- North America
- South Amerca
- Middle east&Africa
- Europe
- Asia pacific
Key Players in the Plasma Fractionation Market
The plasma fractionation market exhibits a moderately concentrated competitive environment, featuring several established global leaders who drive capacity and supply. Among the main companies shaping market developments are:
- CSL Behring
- Grifols S.A
- Octapharma
- Kedrion S.p.A
- Bio Products Laboratory Ltd.
These companies leverage extensive donation networks, manufacturing capabilities, and global distribution systems to maintain leadership in the plasma fractionation field. Their ongoing investments in process improvements and product portfolios contribute to overall plasma fractionation market growth.
Conclusion:
Looking ahead, the plasma fractionation market is expected to continue its upward trajectory, supported by robust demand for plasma-derived medicines in clinical settings and broader healthcare strategies that emphasize patient-centered care. The synergy of product diversification, expanding treatment applications, and regional infrastructure enhancements underscores a positive direction for the market.
As stakeholders adopt innovative approaches from home-based therapy models to new fractionation technologies growth opportunities will remain accessible across segments and geographies. Continued monitoring of demand patterns and investment trends will be essential for companies seeking to navigate evolving market dynamics and capitalize on emerging opportunities in the plasma fractionation landscape.
Industry related Reports:
Blood Preparation Market : The Blood Preparation Market Report is Segmented by Product Type (Whole Blood, Blood Components, and Blood Derivatives), Blood Thinning Agents (Anticoagulants, and More), Application (Thrombocytosis, and More), End User (Hospitals & Surgical Centers, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America).
Biotechnology Market : Biotechnology Market Report Segments the Industry Into by Technology (DNA Sequencing, Nanobiotechnology and More), Application (Health & Red Biotechnology, Food and Agriculture and More), End User (Biopharma & Biotechnology Companies, Cmos & CROs and More), Product Type (Biopharmaceuticals, Bioprocess Equipment & Consumables and More), and Geography.
Biopreservation Market : The Biopreservation Market Report is Segmented by Product Type (Biopreservation Media and Equipment [Temperature-Maintaining Units, Consumables and More), Biospecimen ( Human Tissues and More), Preservation Method (Cryopreservation, Vitrification and More), Application Area (Biobanking and More), End User (Biobanks & Gene Banks, and More), and Geography.
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
